| Phase 4 |
| NCT05787509 |
Prolonged Progesterone to Prevent Preterm Birth From IVF - ET |
Preterm Birth |
Recruiting |
| Phase 3 |
| NCT06966245 |
External Mastalgia-oil Versus Placebo in Premenopausal Women With Severe Mastalgia |
Mastalgia |
Recruiting |
| NCT07137832 |
OPtimizing REperfusion by Intra-Arterial ThRomboLysis as Adjunct to Endovascular… |
Acute Ischemic Stroke |
Recruiting |
| NCT06889688 |
Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in… |
Breast Cancer Stage IV |
Recruiting |
| NCT07400523 |
Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual… |
Breast Cancer |
Recruiting |
| NCT07371910 |
Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced… |
Metastatic Breast Cancer |
Active, Not Recruiting |
| NCT06144944 |
Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer |
Breast Cancer Invasive |
Active, Not Recruiting |
| NCT05165069 |
The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand… |
Hand-foot Syndrome |
Active, Not Recruiting |
| NCT07606807 |
rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window |
Acute Ischemic Stroke |
Not Yet Recruiting |
| Phase 2 |
| NCT07037199 |
Efficacy and Safety of Trastuzumab Rezetecan Followed by CDK4/6 Inhibitors and Endocrine… |
Advanced Breast Cancer |
Recruiting |
| NCT05430698 |
PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma |
Perihilar Cholangiocarcinoma |
Recruiting |
| NCT07401537 |
Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval… |
Triple -Negative Breast Cancer |
Recruiting |
| NCT07595770 |
Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell… |
Esophageal Squamous Cell Carcinoma (ESCC) |
Recruiting |
| NCT06339619 |
Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and… |
Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma |
Recruiting |
| NCT04872985 |
Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer |
Breast Cancer |
Active, Not Recruiting |
| NCT07401654 |
The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin… |
Ovarian Cancer |
Not Yet Recruiting |
| NCT07408648 |
A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of… |
Chemotherapy Induced Thrombocytopenia |
Not Yet Recruiting |
| NCT07205497 |
QL1706 Plus Neoadjuvant Chemotherapy Followed by Type I Hysterectomy for Locally Advanced… |
Neoadjuvant Immunotherapy |
Active, Not Recruiting |
| NCT07618390 |
A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of… |
Breast Cancer |
Not Yet Recruiting |
| NCT06511726 |
Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer |
Cervical Cancer |
Active, Not Recruiting |
| NCT07630103 |
Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast… |
Advanced Breast Cancer |
Not Yet Recruiting |
| Phase 1/2 |
| NCT07595900 |
Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis |
Granulomatous Lobular Mastitis |
Not Yet Recruiting |
| Phase 1 |
| NCT07467122 |
Exploratory Clinical Study of TCR-T for MAGE-A4-positive Mesenchymal Malignancies |
Advanced Mesenchymal Malignancies |
Recruiting |
| NCT07353294 |
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC |
Bladder Urothelial Carcinoma |
Enrolling by Invitation |
| Not specified |
| NCT07357571 |
Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by… |
Thyroid Papillary Carcinoma |
Recruiting |